228 related articles for article (PubMed ID: 23325639)
1. In vivo imaging of lymph node lymphangiogenesis by immuno-positron emission tomography.
Mumprecht V; Detmar M
Methods Mol Biol; 2013; 961():129-40. PubMed ID: 23325639
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.
Mumprecht V; Honer M; Vigl B; Proulx ST; Trachsel E; Kaspar M; Banziger-Tobler NE; Schibli R; Neri D; Detmar M
Cancer Res; 2010 Nov; 70(21):8842-51. PubMed ID: 20978206
[TBL] [Abstract][Full Text] [Related]
3. Inflammation-induced lymph node lymphangiogenesis is reversible.
Mumprecht V; Roudnicky F; Detmar M
Am J Pathol; 2012 Mar; 180(3):874-879. PubMed ID: 22200615
[TBL] [Abstract][Full Text] [Related]
4. Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery.
Proulx ST; Luciani P; Dieterich LC; Karaman S; Leroux JC; Detmar M
J Control Release; 2013 Dec; 172(2):550-7. PubMed ID: 23665257
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis.
Lee AS; Kim DH; Lee JE; Jung YJ; Kang KP; Lee S; Park SK; Kwak JY; Lee SY; Lim ST; Sung MJ; Yoon SR; Kim W
Cancer Res; 2011 Jul; 71(13):4506-17. PubMed ID: 21586615
[TBL] [Abstract][Full Text] [Related]
6. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.
Van der Auwera I; Van den Eynden GG; Colpaert CG; Van Laere SJ; van Dam P; Van Marck EA; Dirix LY; Vermeulen PB
Clin Cancer Res; 2005 Nov; 11(21):7637-42. PubMed ID: 16278382
[TBL] [Abstract][Full Text] [Related]
7. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
8. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
9. Interaction of tumor cells and lymphatic vessels in cancer progression.
Alitalo A; Detmar M
Oncogene; 2012 Oct; 31(42):4499-508. PubMed ID: 22179834
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein inhibits lymphangiogenesis and resultant lymph node metastasis of squamous cell carcinoma in mice.
Sasaki T; Motoyama S; Sato Y; Yoshino K; Matsumoto G; Minamiya Y; Saito H; Murata K; Ogawa J
Surgery; 2013 Nov; 154(5):1087-92. PubMed ID: 23859309
[TBL] [Abstract][Full Text] [Related]
11. Tumor-induced lymphangiogenesis: a target for cancer therapy?
Thiele W; Sleeman JP
J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
[TBL] [Abstract][Full Text] [Related]
12. Significance of lymphatic invasion on regional lymph node metastasis in early gastric cancer using LYVE-1 immunohistochemical analysis.
Fujimoto A; Ishikawa Y; Akishima-Fukasawa Y; Ito K; Akasaka Y; Tamai S; Maehara T; Kiguchi H; Ogata K; Nishimura C; Miki K; Ishii T
Am J Clin Pathol; 2007 Jan; 127(1):82-8. PubMed ID: 17145628
[TBL] [Abstract][Full Text] [Related]
13. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization.
Angeli V; Ginhoux F; Llodrà J; Quemeneur L; Frenette PS; Skobe M; Jessberger R; Merad M; Randolph GJ
Immunity; 2006 Feb; 24(2):203-15. PubMed ID: 16473832
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor.
Yuanming L; Feng G; Lei T; Ying W
Arch Med Res; 2007 Jan; 38(1):106-12. PubMed ID: 17174733
[TBL] [Abstract][Full Text] [Related]
15. The lymph vessel network in mouse skin visualised with antibodies against the hyaluronan receptor LYVE-1.
Tripp CH; Haid B; Flacher V; Sixt M; Peter H; Farkas J; Gschwentner R; Sorokin L; Romani N; Stoitzner P
Immunobiology; 2008; 213(9-10):715-28. PubMed ID: 18926287
[TBL] [Abstract][Full Text] [Related]
16. Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue.
Hirota K; Wakisaka N; Sawada-Kitamura S; Kondo S; Endo K; Tsuji A; Murono S; Yoshizaki T
Histopathology; 2012 Dec; 61(6):1065-71. PubMed ID: 22957497
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1.
Hara Y; Torii R; Ueda S; Kurimoto E; Ueda E; Okura H; Tatano Y; Yagi H; Ohno Y; Tanaka T; Masuko K; Masuko T
Cancer Sci; 2018 Oct; 109(10):3171-3182. PubMed ID: 30058195
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
19. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
Tobler NE; Detmar M
J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
